Pharma Journalist 8778 posts 0 comments

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced it has signed an agreement to acquire the Genentech large-scale biologics…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Abecma (idecabtagene vicleucel; ide-cel) for the treatment of adult patients with relapsed and…
Read More...

Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved SPEVIGO (spesolimab-sbzo) injection for the treatment of generalized pustular psoriasis (GPP)…
Read More...

Bristol Myers Squibb announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”). With the acquisition's completion, Karuna shares have ceased…
Read More...

AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).…
Read More...

Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced the U.S. Food and…
Read More...

The future of peptide pharmaceuticals is evolving rapidly, with countless positive readouts, new collaborations and groundbreaking innovations in oral delivery in Q1 of 2024 alone.…
Read More...

Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommends CARVYKTI (ciltacabtagene autoleucel, cilta-cel) for…
Read More...

Novartis announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The US$256 million investment will facilitate Novartis in deploying…
Read More...

Almirall, S.A. and Eloxx Pharmaceuticals, Inc. announced that the companies have entered into an exclusive license agreement for the asset ZKN-013. Under the agreement, Almirall obtains…
Read More...